SGLT2-inhibitor improves skeletal muscle compliance in a rat model of heart failure with preserved ejection fraction: a titin focused study

23 April 2026 (08:00 - 18:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mrs Beatrice Vahle

Heart Centre Dresden - Dresden Technical University Hospital, Dresden (Germany)

5 More presentations in this session

Presentation thumbnail

Elamipretide improves skeletal muscle function in heart failure with preserved ejection fraction rats: a mitochondrial, physiological and molecular analysis

Mrs B. Vahle (Dresden, DE)

Abstract Slides

Presentation thumbnail

Locomotor muscle mass, total body mass, and physical function in older adults

Doctor J. Santos (Arlington, US)

Abstract Slides

Presentation thumbnail

Determinants of six-minute walk distance in heart failure with reduced vs. preserved ejection fraction: a systematic review and meta-regression analysis

Doctor A. Ogura (Sanda, JP)

Abstract Slides

Presentation thumbnail

Factors contributing to intensive care unit-acquired weakness in patients with acute decompensated heart failure

Professor P. Cao (Changzhou, CN)

Abstract Slides

Presentation thumbnail

Muscle mass matters: handgrip strength as a functional marker in hear failure

Assistant Professor T. Ivanova (Varna, BG)

Abstract Slides

Access the full session

Session thumbnail

Heart failure and old age: muscle matters!

The Event

Event poster

ESC Preventive Cardiology 2026

23 April - 25 April 2026

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources